EUVIMEDUpptäck EUVIMED
Crossref

MS4A4A ‐positive tumor‐associated macrophages associate with poor prognosis and T‐cell exhaustion in patients with urothelial carcinoma of the bladder

Tenghao Yang iD, Xi Sun, Jiaming Chen, Jinqing Li, Chaoqun Liu, Jingwei Yu, Weiju Meng, Yongqiang Wang, Hao Yu, Jian Huang, Bo Wang

The Journal of Pathology · 2025-10 · 267 (2) · 225-239

DOI: 10.1002/path.6465 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2025-08-13. Written by Tenghao Yang and 10 co-authors. Institution: Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, PR China. Major MEDLINE topics: Urinary Bladder Neoplasms, Tumor-Associated Macrophages, Biomarkers, Tumor, Carcinoma, Transitional Cell. Cited 2 times so far (Crossref); 58 references. Funded by: Guangdong Provincial Clinical Research Center for Urological Diseases, National Natural Science Foundation of China, The Science and Technology Planning Project of Guangdong Province.

AbstractSubjectsBibliografiska uppgifterCiteRelated studies

Abstract (original language)

Tumor‐associated macrophages (TAMs) have multiple potent functions in cancer representing important therapeutic targets. MS4A4A is a functional TAM marker with controversial implications for prognosis. This study aimed to evaluate the association between MS4A4A + TAM infiltration and clinical outcomes in urothelial carcinoma of the bladder (UCB), as well as their impact on the immune landscape. A total of 400 UCB patients from cohorts at Sun Yat‐sen Memorial Hospital were analyzed. Immunohistochemistry was used to quantify MS4A4A + TAMs and assess their spatial distribution alongside various immune components, evaluate the benefit of Bacillus Calmette‐Guérin (BCG) immunotherapy, and analyze survival outcomes. Additionally, matched UCB tissues were examined before and after recurrence or progression. We observed that MS4A4A + TAMs were present at higher levels in the stromal region compared to the intratumoral region, and correlated with advanced tumor stage and poor prognosis in both regions. No significant difference was observed in the number of MS4A4A + TAMs before and after recurrence/progression in the same patient. Stromal MS4A4A + TAMs were negatively correlated with BCG efficacy and recurrence‐free survival. These TAMs were positively associated with CD8 + T cells, Foxp3 + regulatory T cells, immune checkpoints (PD‐1, LAG‐3, HAVcr‐2, TIGIT), and anti‐inflammatory molecules (TGF‐β1, IL‐4) in the same respective regions. Additionally, MS4A4A + TAMs expressed high levels of TGF‐β1 and HAVcr‐2 in UCB tissues. In vitro , IL‐4 induced MS4A4A expression in mouse bone marrow‐derived macrophages, while Ms4a4a knockdown reduced the anti‐inflammatory molecule Arg1 and increased pro‐inflammatory molecule Nos2 expression. These findings demonstrate that MS4A4A is a reliable prognostic marker and predictor of BCG response in UCB, highlighting its role in shaping the immune landscape and immunotherapy outcomes. © 2025 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Urinary Bladder NeoplasmsTumor-Associated MacrophagesBiomarkers, TumorCarcinoma, Transitional CellLymphocytes, Tumor-InfiltratingHumansMaleFemaleMiddle AgedAgedBCG VaccinePrognosisTumor MicroenvironmentT-Cell Exhaustion

Author keywords

MS4A4AT‐cell exhaustionimmune checkpointmacrophageprognosisurothelial carcinoma of the bladder

Substances

BCG VaccineBiomarkers, Tumor

Authors and institutions

  • Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, PR China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, PR China.
  • Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances and School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, PR China.
  • Division of Hematology & Oncology, Department of Geriatrics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, PR China.
  • Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, PR China.

ORCID profiles: Tenghao Yang

Funding

  • Guangdong Provincial Clinical Research Center for Urological Diseases
  • National Natural Science Foundation of China
  • The Science and Technology Planning Project of Guangdong Province
  • Elite Young Scholars Development Program of Sun Yat-Sen Memorial Hospital to B.W.

Cite

APA

Yang, T., Sun, X., Chen, J., Li, J., Liu, C., Yu, J., Meng, W., Wang, Y., Yu, H., Huang, J., & Wang, B. (2025). MS4A4A ‐positive tumor‐associated macrophages associate with poor prognosis and T‐cell exhaustion in patients with urothelial carcinoma of the bladder. The Journal of Pathology, 267(2), 225-239. https://doi.org/10.1002/path.6465

Vancouver

Yang T, Sun X, Chen J, Li J, Liu C, Yu J, et al. MS4A4A ‐positive tumor‐associated macrophages associate with poor prognosis and T‐cell exhaustion in patients with urothelial carcinoma of the bladder. The Journal of Pathology. 2025;267(2):225-239. doi:10.1002/path.6465

BibTeX
@article{Yang2025,
  author = {Yang, Tenghao and Sun, Xi and Chen, Jiaming and Li, Jinqing and Liu, Chaoqun and Yu, Jingwei and Meng, Weiju and Wang, Yongqiang and Yu, Hao and Huang, Jian and Wang, Bo},
  title = {MS4A4A ‐positive tumor‐associated macrophages associate with poor prognosis and T‐cell exhaustion in patients with urothelial carcinoma of the bladder},
  journal = {The Journal of Pathology},
  year = {2025},
  volume = {267},
  number = {2},
  pages = {225--239},
  doi = {10.1002/path.6465}
}
Start for free →